Table 1.
1 | 50 | ||||
FCV-F9 | ∼∼∼TCCCTGA | TGGCTGGCCT | GACACCACAA | TTCCTGGGGA | GTTGATACCT |
FCV-Ari | ∼∼TACCAGGA | TGGTTGGCCT | GACACCACAA | TCCCTGAGAA | GCTGACACCT |
FCV-2-93 | AGCCCGTAA | AATATCCAAC | ACTGCACCAA | TTCCTGGGGA | GTTGATACCA |
FCV-256660 | ∼GATTCCTGA | CGGATGGCCA | GACACTACTA | TCCCTGAGAA | GCTAATCCCT |
FCV-254075 | ∼AATACCTGA | TGGGTGGCCG | GACACAACAA | TTCCAAGCAA | GCTCACGCCT |
51 | 100 | ||||
FCV-F9 | GCTGGCGATT | ACGCAATCAC | CAATGGTACT | GGCAATGACA | TCACCACGGC |
FCV-Ari | GCTGGCGATT | ACGCCATCGT | AGATGGATCA | GGCAATGACA | TCACAACTAA |
FCV-2-93 | GCTGGCGATT | ACGCAATCAC | CAATGGTACT | GGCAATGACA | TCACCACGGC |
FCV-256660 | GCTGGTGATT | ACGCAATCAC | AACATTAAGT | GGTTCTGACA | TCACAACTCC |
FCV-254075 | GCCGGCAACT | ATGCCATTAC | CAACGGAAGT | GGTAGCGACA | TTGTGACGCC |
101 | 150 | ||||
FCV-F9 | TACAGGATAT | GACACTGCTG | ATATAATTAA | GAACAATACC | AACTTTAGGG |
FCV-Ari | GGATAAATAT | GAAAGTGCTG | ATGTGATCAA | GAATAACACC | AATTTCAGGG |
FCV-2-93 | TACAGGATAT | GACACTGCTG | ATATAATTAA | GAACAATACC | AACTTTAGGG |
FCV-256660 | CCAAGGGTAT | GATAATGCAG | ATGTAATTAA | GAATAATACA | AACTTTAAAG |
FCV-254075 | TGCTGGGTAC | GACTCTGCTG | ATGTCATCCT | GAACAATACA | AACTTTAAGG |
151 | 200 | ||||
Fcv-F9 | GCATGTACAT | ATGTGGTTCG | CTCCAGCGTG | CCTGGGGTGA | CAAGAAAATA |
Fcv-Ari | GCATGTACAT | TTGTGGCTCA | CTTCAAAGAG | CATGGGGTGA | CAAGAAAATA |
Fcv2-93 | GCATGTACAT | ATGTGGTTCG | CTCCAGCGTG | CCTGGGGTGA | CAAGAAAATA |
Fcv-256660 | GAATGTACAT | TTGTGGATCT | TTACAACGAG | CATGGGGTGA | CAAGAAAATA |
Fcv-254075 | GCATGTACAT | CTGTGGTTCC | CTTCAAAGAG | CCTGGGGTGA | CAAGAAAATA |
201 | 213 | ||||
Fcv-F9 | TCCAACACTG | CAT | |||
Fcv-Ari | TCCAACNGGC | A∼∼ | |||
Fcv2-93 | TCCAACACTG | CAA | |||
Fcv-256660 | TCCAACACTG | A∼∼ | |||
Fcv-254075 | TCCAACTGCA | ∼∼∼ |
FCV-Ari falls within the predicted range of genetic variability of both vaccine and field strains.